Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Current Deferred Revenue (2018 - 2025)

Historic Current Deferred Revenue for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $59.2 million.

  • Health Catalyst's Current Deferred Revenue rose 1276.19% to $59.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.2 million, marking a year-over-year increase of 1276.19%. This contributed to the annual value of $53.5 million for FY2024, which is 412.19% down from last year.
  • Per Health Catalyst's latest filing, its Current Deferred Revenue stood at $59.2 million for Q3 2025, which was up 1276.19% from $67.3 million recorded in Q2 2025.
  • Health Catalyst's Current Deferred Revenue's 5-year high stood at $71.9 million during Q1 2025, with a 5-year trough of $52.5 million in Q3 2024.
  • Its 5-year average for Current Deferred Revenue is $58.9 million, with a median of $56.7 million in 2022.
  • In the last 5 years, Health Catalyst's Current Deferred Revenue soared by 5395.1% in 2021 and then plummeted by 582.01% in 2023.
  • Health Catalyst's Current Deferred Revenue (Quarter) stood at $57.6 million in 2021, then decreased by 4.34% to $55.1 million in 2022, then increased by 1.27% to $55.8 million in 2023, then decreased by 4.12% to $53.5 million in 2024, then rose by 10.65% to $59.2 million in 2025.
  • Its last three reported values are $59.2 million in Q3 2025, $67.3 million for Q2 2025, and $71.9 million during Q1 2025.